Gold vs US Dollar

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
NASDAQ
Akari Therapeutics PLC (AKTX)
Akari Therapeutics PLC (AKTX) Financials

AKTX Akari Therapeutics PLC

0.98

-0.02 (-2.00%)

12 Dec 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-45.305	-69.942	-73.633	-146.921	-162.03	-132.739	-122.091	-112.345
Return on Equity (%)	-49.404	-80.468	-90.031	-251.733	-363.756	-233.269	-315.194	-393.127
Return on Invested Capital (%)	-51.315	-80.292	-103.518	-250.807	-371.529	-230.819	-409.509	-577.602
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	0.035	0.02	0.008	N/A	0.004	0.001	0.001	N/A
Earnings Per Share	-0.022	-0.019	-0.013	-0.011	-0.008	-0.004	-0.002	-0.001
Cash Per Share	0.029	0.019	0.004	0.004	0.006	0.002	0.002	N/A
Working Capital Per Share	0.035	0.02	0.008	N/A	0.004	0.001	0.001	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	-0.022	-0.025	-0.015	-0.011	-0.008	-0.004	-0.003	-0.001
EBITDA Per Share	-0.022	-0.025	-0.015	-0.011	-0.008	-0.004	-0.003	-0.001
Free Cash Flow Per Share	-0.022	-0.019	-0.013	-0.011	-0.008	-0.004	-0.002	-0.001

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	1.18B	1.53B	1.58B	1.58B	2.25B	4.76B	7.44B	13.23B

Key Stats and Ratios

Year End 31 December 2023	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	N/A	2.25B	N/A	N/A	N/A	4.76B	N/A	5.93B
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	24.76M
Price to Earnings Ratio	-1.98
Price to Sales Ratio	73.68
Price to Cash Ratio	6.31
Price to Book Ratio	24.56
Dividend Yield	-

Share Statistics

Shares Outstanding	24.76M
Average Volume (1 week)	0
Average Volume (1 Month)	0
52 Week Change	-
52 Week High	-
52 Week Low	-

More Ratios Coming Soon!

Akari Therapeutics

Urca Hedg Fund Estrategi...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions